GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Edwards Lifesciences
Edwards Lifesciences is a pioneer in developing technologies to treat heart disease, particularly valves. Its stock is a history of medical innovation. Each successful product, enabling less invasive surgeries, pushes the company's value to new heights.
Share prices of companies in the market segment - Specialized medical equipment
Edwards Lifesciences is a leader in the production of artificial heart valves, particularly for transcatheter endovascular implantation (TAVI). We classify it in the Specialized Medical Equipment sector, and the chart below reflects the dynamics of this segment, driven by an aging population.
Broad Market Index - GURU.Markets
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring systems. Its innovations make it a key component of the GURU.Markets index. The chart below represents the market. See how demographic trends are impacting Edwards' business.
Change in the price of a company, segment, and market as a whole per day
EW - Daily change in the company's share price Edwards Lifesciences
Edwards Lifesciences is a global leader in the production of artificial heart valves and hemodynamic monitoring systems. Its daily share price change is a measure of volatility in the medical technology sector. This metric is important for the analytical formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Edwards Lifesciences Corporation is a leader in the artificial heart valve market. This chart shows the average daily volatility of the MedTech sector. Comparing it with EW's performance helps us understand how demographic trends and innovation make its business resilient to economic cycles.
Daily change in the price of a broad market stock, index - GURU.Markets
Edwards Lifesciences is a leader in artificial heart valves and hemodynamic monitoring. The medical technology market is growing rapidly, but it is also highly competitive. The chart below shows the volatility in this sector, helping to assess how Edwards' shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Edwards Lifesciences
Edwards Lifesciences is a leader in the development and production of artificial heart valves. The year-over-year share price performance, shown in the chart, reflects the stable demand for its products, driven by an aging population and innovations in cardiac surgery.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Edwards Lifesciences Corporation specializes in the production of artificial heart valves and hemodynamic monitoring. The company is a leader in its niche thanks to continuous innovation. An aging population ensures long-term demand for its products, allowing it to demonstrate stable growth in the medical equipment sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Edwards Lifesciences is a leader in the production of artificial heart valves and other technologies for the treatment of cardiovascular diseases. The company's growth is driven by an aging population and the introduction of minimally invasive procedures. Its stock price reflects this long-term demographic and technological trend.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Edwards Lifesciences
Edwards Lifesciences' (EW) market capitalization dynamics based on Perf_Month_Co reflect operating cycles associated with the introduction of its innovative heart valves and monitoring equipment. Medium-term fluctuations in the chart reflect how the market perceives its ability to expand indications, success in clinical trials, and demand from healthcare institutions.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
This chart shows the dynamics of the medical technology sector, particularly in cardiology, where Edwards is a leader. Its movements reflect demand for its transcatheter heart valves, driven by an aging population and the shift toward minimally invasive procedures.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring. Demand for its products is driven by medical needs, not the state of the economy. A broad market chart provides a good backdrop for how innovation and an aging population have driven Edwards' stock, often regardless of market panics.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Edwards Lifesciences
Edwards Lifesciences, a company specializing in artificial heart valves, shares weekly reflect progress in cardiovascular treatment. Price movements reflect clinical trial results, demographic trends such as an aging population, and the introduction of less invasive technologies.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
The specialized medical equipment sector is a story of innovation and demographics. The weekly dynamics of the entire industry reflect the adoption of new technologies in hospitals to treat age-related conditions. The chart illustrates this overall backdrop, with Edwards Lifesciences leading the way in cardiac treatment.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Edwards Lifesciences is a leader in the production of artificial heart valves and other cardiac devices. Demand for its products is driven by serious medical indications. The chart below shows how Edwards shares are a "defensive" medical stock, less susceptible to market turbulence.
Market capitalization of the company, segment and market as a whole
EW - Market capitalization of the company Edwards Lifesciences
Edwards Lifesciences' market capitalization chart tells a story of leadership and innovation in the treatment of structural heart disease. Its robust growth reflects the success of transcatheter aortic valve replacement (TAVI), a technology that eliminates the need for open-heart surgery. Its growth reflects the market's appreciation of technologies that save lives and change the standard of care.
EW - Share of the company's market capitalization Edwards Lifesciences within the market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring systems. Its dominant market share, particularly in transcatheter valves, reflects its technological superiority. The chart shows how life-saving innovations have created a company with immense value.
Market capitalization of the market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in the production of artificial heart valves and transcatheter implantation systems. The chart below shows the market capitalization of the medical device sector. Its dynamics reflect both overall healthcare spending and breakthrough innovations that are changing treatment standards.
Market capitalization of all companies included in a broad market index - GURU.Markets
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring. Its market capitalization reflects innovation in the treatment of cardiovascular diseases, particularly in the aging population. Its growth chart reflects the pulse of cutting-edge medicine that saves lives.
Book value capitalization of the company, segment and market as a whole
EW - Book value capitalization of the company Edwards Lifesciences
Edwards Lifesciences' foundation is its high-tech manufacturing facilities for artificial heart valves and research centers. Its book value reflects tangible, knowledge-intensive capital that saves lives. How has this innovative medical asset grown? The chart below shows the dynamics of its robust development.
EW - Share of the company's book capitalization Edwards Lifesciences within the market segment - Specialized medical equipment
Edwards Lifesciences manufactures high-tech heart valves in specialized sterile facilities. The chart shows the share of these unique and critical tangible assets in the medical device sector, reflecting the physical scale of its lifesaving innovations.
Market segment balance sheet capitalization - Specialized medical equipment
Manufacturing high-tech medical devices like Edwards heart valves is capital-intensive. Given its healthcare assets, the need to own sterile manufacturing facilities and R&D centers makes the company a "heavy" innovator.
Book value of all companies included in the broad market index - GURU.Markets
Edwards Lifesciences' book value reflects its high-tech, clean-sheet manufacturing operations, which create artificial heart valves and other cardiac surgery equipment. The company's assets reflect its production and scientific potential to save lives. The chart shows the physical weight of this medical technology leader.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Edwards Lifesciences
Edwards Lifesciences, a leader in artificial heart valve production, is valued by the market at a multiple of its manufacturing value. This premium reflects its life-saving innovations, its strong patents, and an aging population that ensures steady demand for its products.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Edwards Lifesciences is a leader in artificial heart valves and hemodynamic monitoring. Its value lies in its patents and clinical data. This chart shows that investors are willing to pay a high premium for its technological leadership and life-saving innovations.
Market to book capitalization ratio for the market as a whole
Edwards Lifesciences is a leader in the production of artificial heart valves and other cardiac devices. The company's value lies in its patents, clinical data, and reputation with surgeons. This metric reflects the high premium the market places on innovations in medical technologies that save lives and improve their quality.
Debts of the company, segment and market as a whole
EW - Company debts Edwards Lifesciences
Edwards Lifesciences, a leader in artificial heart valves, funds its expensive research and clinical trials primarily through strong profits from existing products. The company maintains low debt, giving it flexibility. This chart illustrates a financial strategy based on technological leadership and organic growth.
Market segment debts - Specialized medical equipment
Edwards Lifesciences is a leader in the development of artificial heart valves and other technologies for the treatment of cardiovascular diseases. This is an innovative industry that requires significant investment in clinical research. This chart shows how the company finances its growth, balancing profit reinvestment with the use of debt to develop breakthrough medical technologies.
Market debt in general
Edwards Lifesciences specializes in the production of artificial heart valves and hemodynamic monitoring. This is a high-tech and rapidly growing field of medicine. This chart allows you to assess the company's reliance on external funding for its expensive research and development and compare its financial policies with overall market trends.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Edwards Lifesciences
Edwards Lifesciences, a manufacturer of innovative heart valves, invests heavily in R&D. This chart shows its financial structure. Low debt reflects the company's ability to fund expensive research with strong cash flow from its successful products, a sign of financial health.
Market segment debt to market segment book capitalization - Specialized medical equipment
Edwards Lifesciences, a leader in artificial heart valves and hemodynamic monitoring. This chart compares the company's debt to the overall market capitalization of the entire medical device sector. It helps understand how the company finances its expensive research and clinical trials to create innovative, life-saving products.
Debt to book value of all companies in the market
Edwards Lifesciences, a manufacturer of cardiac medical devices, operates in the defensive healthcare sector. This chart compares the company's debt to the overall market capitalization. It helps understand how stable the company's financial policy, supported by an aging population, is and how unaffected it is by short-term economic downturns.
P/E of the company, segment and market as a whole
P/E - Edwards Lifesciences
Edwards Lifesciences is a leader in artificial heart valves and other technologies for the treatment of structural heart disease. This chart shows the premium investors pay for its innovative, life-saving products. This high valuation reflects an aging population and growing demand for minimally invasive cardiac procedures.
P/E of the market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring. The company focuses on the treatment of structural heart disease. This chart shows the average rating for medical device manufacturers, helping to understand how the market values Edwards' leadership and innovation in this vital field.
P/E of the market as a whole
Edwards Lifesciences is a leader in the development of artificial heart valves and other cardiac technologies. Demand for its products is driven by an aging population and medical needs. To what extent is its valuation isolated from the general market cycles reflected in this chart? Or does it still depend on hospital budgets and the overall economic situation?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Edwards Lifesciences
Edwards Lifesciences is a leader in the production of artificial heart valves and other technologies for the treatment of structural heart disease. The company's future profitability depends on the aging population and the adoption of its innovative medical devices. This chart shows market expectations for increased demand for minimally invasive cardiac procedures.
%20P%2FE%20Edwards%20Lifesciences&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Edwards-Lifesciences&v=1772618113902 "Chart of the company's future (projected) P/E Edwards Lifesciences")
Future (projected) P/E of the market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in the production of artificial heart valves and transcatheter valve implantation (TAVI) systems, a less invasive alternative to open heart surgery. This chart shows how the market views Edwards' profitability prospects, reflecting expectations for the growing popularity of the TAVI procedure and an aging population.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772618113984 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
Edwards Lifesciences specializes in the production of artificial heart valves and hemodynamic monitoring. Their growth is driven by an aging population and medical innovations. This graph of overall market expectations highlights that demand for their vital products remains strong regardless of the economic climate.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772618114024 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Edwards Lifesciences
Edwards Lifesciences is a leader in the development of artificial heart valves, particularly transcatheter-assisted intravascular valve implants (TAVI). This chart illustrates how medical innovations can create huge markets. The company's profit growth is directly linked to the spread of its minimally invasive procedures, which are becoming the standard of care.
Profit of companies in the market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring. This chart shows profitability in the specialized medical equipment sector. The company's innovations, particularly in transcatheter valve replacement, are changing the standard of care and securing its dominant position in the market.
Overall market profit
Edwards Lifesciences specializes in the production of artificial heart valves and hemodynamic monitoring. Demand for its products is driven by the medical needs of an aging population and is not affected by short-term economic fluctuations. However, the overall situation reflected in this chart may impact hospital budgets and their ability to purchase advanced equipment.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Edwards Lifesciences
Edwards Lifesciences is a global leader in the production of artificial heart valves and transcatheter valve implantation (TAVI) systems. This chart shows analysts' expectations for future revenue. The forecast is driven by an aging population and the growing adoption of minimally invasive TAVI procedures, which are becoming the standard of care.
%20profit%20of%20the%20company%20Edwards%20Lifesciences&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Edwards-Lifesciences&v=1772618114309 "Graph of future (projected) profit of the company Edwards Lifesciences")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring. The medical device sector revenue forecasts presented here demonstrate the demand for innovative solutions for an aging population. This allows us to assess how Edwards' minimally invasive technologies are changing approaches to treating heart disease.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772618114423 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
Edwards Lifesciences specializes in the production of artificial heart valves and hemodynamic monitoring systems. Demand for its vital products is largely independent of economic cycles. However, the overall economic situation, reflected in this chart, impacts healthcare budgets and patients' ability to afford expensive procedures.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772618114573 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Edwards Lifesciences
Edwards Lifesciences is a leader in the development of artificial heart valves and other technologies for the treatment of cardiovascular diseases. This chart shows how highly investors value the revenue from their innovative medical devices. This high figure reflects an aging population and growing demand for their life-saving technologies.
P/S market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring. The company is a pioneer in transcatheter aortic valve replacement (TAVR). This chart shows the average market value for the sector, helping to understand how the market values Edwards' innovation and dominance in saving patients' lives.
P/S of the market as a whole
Edwards Lifesciences specializes in the development of artificial heart valves and hemodynamic monitoring. It is a pioneer in transcatheter aortic valve replacement (TAVR). This chart shows how the market values the revenue of this innovative medical device company compared to the overall market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Edwards Lifesciences
Edwards Lifesciences is a company specializing in artificial heart valves and hemodynamic monitoring. This chart shows investors' high expectations for its future earnings. This valuation is fueled by an aging population and the growing adoption of its minimally invasive technologies for treating heart disease.
%20P%2FS%20Edwards%20Lifesciences&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Edwards-Lifesciences&v=1772618114705 "The graph of the company's future (projected) P/S Edwards Lifesciences")
Future (projected) P/S of the market segment - Specialized medical equipment
Edwards Lifesciences specializes in the production of artificial heart valves and hemodynamic monitoring. This chart compares the company's estimated future sales with other medical device manufacturers. It reflects investor expectations for growing demand for its innovative transcatheter valves, which enable less invasive surgeries.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772618114783 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
Edwards Lifesciences specializes in the production of artificial heart valves and other cardiac devices. Demand for its products is driven by an aging population and the prevalence of cardiovascular disease. This overall market outlook is less important to Edwards than demographic trends and medical innovations, which drive its long-term growth.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772618114894 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Edwards Lifesciences
This figure reflects the revenue of Edwards Lifesciences, a leading manufacturer of artificial heart valves and hemodynamic monitoring systems. Revenue growth is driven by an aging population and the spread of cardiovascular diseases, as well as the introduction of innovative technologies such as transcatheter valve replacement, which allows for less invasive procedures.
Sales of companies in the market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in the production of artificial heart valves and transcatheter valve implantation (TAVI) systems. The company's technologies enable heart surgery without opening the chest. This chart shows revenue in the specialized medical equipment sector. It reflects an aging population and the growing demand for minimally invasive heart treatments.
Overall market sales
Edwards Lifesciences specializes in the production of artificial heart valves and hemodynamic monitoring. Demand for its vital products is driven by an aging population and medical needs. Economic cycles, as reflected in this chart, have minimal impact on the company, as cardiac surgeries are rarely postponed due to economic considerations.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Edwards Lifesciences
Edwards Lifesciences specializes in the development of artificial heart valves and hemodynamic monitoring. This revenue forecast chart reflects demand for its innovative medical devices. The growth is driven by expectations of an increase in the number of cardiac surgeries, particularly minimally invasive ones, for which the company's products are standard.
%20sales%20of%20the%20company%20Edwards%20Lifesciences&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Edwards-Lifesciences&v=1772618115146 "Schedule of future (projected) sales of the company Edwards Lifesciences")
Future (projected) sales of companies in the market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in the production of artificial heart valves and transcatheter implantation systems. The company's technologies enable complex heart surgeries without opening the chest. This chart shows projected revenue for the specialized medical equipment sector, reflecting an aging population and demand for innovative treatments.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772618115175 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
Edwards Lifesciences specializes in the production of artificial heart valves and hemodynamic monitoring. Demand for its products is driven by an aging population and medical needs. However, the stable economic growth projected by the market ensures sustainable funding for healthcare systems, making its life-saving technologies accessible.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772618115229 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Edwards Lifesciences
Edwards Lifesciences is a leader in the production of artificial heart valves and other technologies for the treatment of structural heart disease. This chart demonstrates high profitability driven by innovation and strong patents. The company's dominance in its niche allows it to command high prices for its life-saving products and be highly efficient.
Market segment marginality - Specialized medical equipment
Edwards Lifesciences specializes in the production of artificial heart valves and hemodynamic monitoring. Its success depends on the profitability of innovative medical devices for the treatment of structural heart diseases. This chart shows the average profitability in the sector, allowing one to assess the strength of Edwards' technological position in this market.
Market marginality as a whole
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring. Demand for its products is driven not by economic cycles, as reflected in this chart, but by the medical needs of an aging population. Innovation and clinical data are key growth drivers, making the company's business recession-resistant.
Employees in the company, segment and market as a whole
Number of employees in the company Edwards Lifesciences
Edwards Lifesciences is a global leader in the production of artificial heart valves and other technologies for the treatment of structural heart disease. This chart illustrates the size of its highly skilled team of engineers, clinicians, and manufacturing personnel, whose work directly saves and improves the lives of thousands of patients.
Share of the company's employees Edwards Lifesciences within the market segment - Specialized medical equipment
Edwards Lifesciences is a medical technology company specializing in artificial heart valves. Manufacturing these vital, complex devices requires a highly skilled and significant workforce. This chart highlights its leadership in cardiovascular technology, demonstrating the concentration of specialized manufacturing and research talent.
Number of employees in the market segment - Specialized medical equipment
Edwards Lifesciences is a global leader in artificial heart valves, particularly in transcatheter in-vitro ablation (TAVI) technologies that eliminate the need for open-heart surgery. This chart illustrates the growing market for medical technologies for an aging population. Continued hiring of engineers and clinicians reflects innovation and the growing use of minimally invasive procedures.
Number of employees in the market as a whole
Edwards Lifesciences is a leader in the production of heart valves and other cardiac devices. Its growth in highly qualified personnel is driven by an aging population and technological breakthroughs in the treatment of cardiovascular diseases.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Edwards Lifesciences (EW)
Edwards Lifesciences is a leader in the production of artificial heart valves. Their value lies in their patents and clinical data proving the superiority of their products. This is a very high-yield strategy for them. This is a business where intellectual property and reputation with doctors create enormous value, generated by a team of highly skilled engineers and scientists.
%20of%20the%20company%20Edwards%20Lifesciences%20(EW)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Edwards-Lifesciences-EW&v=1772618115882 "Chart of market capitalization per employee (in thousands of dollars) of the company Edwards Lifesciences (EW)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Edwards Lifesciences is a leader in the production of artificial heart valves, particularly for transcatheter endovascular valve replacement (TAVR). It is a high-tech R&D company with strong patents. This metric, compared to the industry average, reflects the premium the market pays for their lifesaving innovations and their strong market position per employee.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772618115919 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Edwards Lifesciences specializes in the production of artificial heart valves and hemodynamic monitoring. This rank reflects its leadership in the high-tech medical niche. The company's innovative products save lives, ensuring high margins and a strong market position, as well as recognition for the contributions of its team.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772618115936 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Edwards Lifesciences (EW)
Edwards Lifesciences is a leader in artificial heart valves, particularly in the field of transcatheter endovascular valve replacement (TAVI). This is high-tech medicine. This chart demonstrates the value of their innovations. Their high profit per employee is a direct result of the high price and margins of their life-saving, patented medical devices.
%20Chart%20Edwards%20Lifesciences%20(EW)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Edwards-Lifesciences-EW&v=1772618115958 "Company Profit Per Employee (in thousands of dollars) Chart Edwards Lifesciences (EW)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Edwards Lifesciences is a leader in the production of TAVR heart valves. This chart shows the benchmark for "Specialized Medical Equipment." The average profit per employee is high here. It's an "R&D-driven business." The benchmark reflects the high margins on patented, life-saving devices that recoup the enormous costs of clinical trials.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772618116015 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Edwards Lifesciences is a global leader in artificial heart valves and hemodynamic monitoring. It's a high-tech company that saves lives. This chart shows the high profit per employee generated by this company, which creates unique and critical medical equipment.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772618116041 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Edwards Lifesciences (EW)
Edwards Lifesciences is a leader in artificial heart valves and hemodynamic monitoring. This chart demonstrates the value of their lifesaving medical innovations. Their high revenue per employee reflects the premium pricing of their products and the trust they have earned from surgeons and hospitals worldwide.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Edwards-Lifesciences-EW&v=1772618116094 "Sales chart per company employee Edwards Lifesciences (EW)")
Sales per employee in the market segment - Specialized medical equipment
Edwards Lifesciences is a leader in the production of transcatheter endovascular valves (TAVR), a revolutionary medical technology. Their business encompasses R&D, precision manufacturing, and physician training. This chart shows the industry average per employee revenue. It helps assess the productivity of their R&D investments and the demand for their technology.
Sales per employee for the market as a whole
Edwards Lifesciences is a leader in the production of artificial heart valves, particularly transcatheter (TAVR) valves, which are implanted without open-heart surgery. This cutting-edge medical technology reflects how their team of engineers and physicians creates high-margin, life-saving devices while generating high revenue.
Short shares by company, segment and market as a whole
Shares shorted by company Edwards Lifesciences (EW)
Edwards Lifesciences specializes in artificial heart valves, particularly minimally invasive replacement (TAVR). This chart measures bearish sentiment. Skeptics may fear increased competition from Medtronic or Abbott in the lucrative TAVR segment or delays in approval of new generations of valves.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Edwards-Lifesciences-EW&v=1772618116367 "Short Shares Chart for the Company Edwards Lifesciences (EW)")
Shares shorted by market segment - Specialized medical equipment
Edwards Lifesciences is a company specializing in medical technologies for the treatment of structural heart disease, primarily known for its transcatheter TAVR valves. This chart reveals skepticism. Shorting Edwards is a bet on competition. Investors may fear that new, more advanced valves from competitors (like Medtronic) will take away market share in the highly profitable TAVR segment.
Shares shorted by the overall market
Edwards Lifesciences is a leader in artificial heart valves, particularly the minimally invasive TAVR technology. It's a non-discretionary company. This market fear has virtually no impact on demand for EW products. Lifesaving procedures aren't being postponed due to recessions. Edwards' business is driven by demographics and medical indications, not economic cycles.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Edwards Lifesciences (EW)
Edwards Lifesciences specializes in heart valves, particularly TAVR (transcatheter endovascular valve replacement). Growth depends on the volume of elective surgeries. This oscillator, above 70, may reflect strong demand for procedures or the success of new products. A level below 30 may reflect concerns about pressure on hospital budgets or competition.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Edwards-Lifesciences-EW&v=1772618116544 "RSI 14 indicator chart for the company's stock Edwards Lifesciences (EW)")
RSI 14 Market Segment - Specialized medical equipment
Edwards Lifesciences (EW) is a leader in the treatment of structural heart disease, known for its TAVR valves, which allow for valve replacement without open-heart surgery. This metric measures the "temperature" of the sector. It helps us understand whether EW is overheated due to its innovative technology or whether the entire medical device sector is overbought.
RSI 14 for the overall market
Edwards Lifesciences is a leader in artificial heart valves and hemodynamic monitoring. It's a high-tech medical business that saves lives. This chart gauges overall investor sentiment. It helps us understand whether EW's fluctuations are driven by general market panic or euphoria in the medical technology sector, rather than the success of its innovative products.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast EW (Edwards Lifesciences)
Edwards Lifesciences is a pioneer in structural heart disease. The company dominates the TAVR (minimally invasive aortic valve replacement) market. This chart represents a collective 12-month analyst forecast. It reflects their expectations for the growth of TAVR procedures worldwide and the success of their new heart valve treatment products.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-EW-Edwards-Lifesciences&v=1772618116833 "A chart showing analyst consensus forecasts for the expected stock price. EW (Edwards Lifesciences)")
The difference between the consensus estimate and the actual stock price EW (Edwards Lifesciences)
Edwards Lifesciences (EW) is a leader in the treatment of structural heart disease, known for its innovative transcatheter ventricular aortic valve replacement (TAVR), which allows for valve replacement without opening the chest. This chart shows the medtech's valuation. It measures the gap between the price and the consensus estimate, reflecting the potential analysts see for their dominance in the TAVR market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-EW-Edwards-Lifesciences&v=1772618116862 "A chart showing the difference between the consensus forecast and the actual stock price. EW (Edwards Lifesciences)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Edwards Lifesciences is a leader in innovative cardiac solutions, known for its transcatheter assisted resuscitation (TAVR) valves, which allow for heart repair without opening the chest. This chart shows the general expectations of analysts for the MedTech sector. It reflects whether experts believe there will be a rise in the number of high-tech procedures.
Analysts' consensus forecast for the overall market share price
Edwards Lifesciences is a pioneer in artificial heart valves, particularly transcatheter assisted resection (TAVR) technologies that help avoid open-heart surgery. Demand for their products is driven by an aging population. This chart reflects overall market sentiment. For Edwards, which operates in the high-tech but protective medical equipment sector, overall optimism is important, but not as critical as for cyclical companies.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Edwards Lifesciences
Edwards Lifesciences is a company specializing in the treatment of structural heart disease. They are a pioneer and leader in transcatheter aortic valve replacement (TAVR). This chart reflects the market acceptance of their breakthrough, less invasive technology. It measures the growth in TAVR procedures, which replace traditional open-heart surgery.
AKIMA Market Segment Index - Specialized medical equipment
Edwards Lifesciences is a leader in innovative heart treatments, known primarily for its revolutionary TAVR (minimally invasive aortic valve replacement) technology. This composite metric evaluates companies. The chart shows the sector average. This benchmark: how does Edwards' technological leadership in cardiology differentiate it from the average competitor?
The AKIM Index for the overall market
Edwards Lifesciences is a leader in the treatment of structural heart disease, known for its innovative transcatheter ventricular aortic valves (TAVR), which eliminate the need for open-heart surgery. This chart, showing the market average, provides context. It helps assess how this MedTech company, dependent on elective surgeries, compares to the overall macroeconomic environment that impacts hospital budgets.
